109 related articles for article (PubMed ID: 19665041)
21. Induction of HLA-G expression in a melanoma cell line OCM-1A following the treatment with 5-aza-2'-deoxycytidine.
Yan WH; Lin AF; Chang CC; Ferrone S
Cell Res; 2005 Jul; 15(7):523-31. PubMed ID: 16045815
[TBL] [Abstract][Full Text] [Related]
22. Human leukocyte antigen-G1 inhibits natural killer cytotoxicity through blocking the activating signal transduction pathway and formation of activating immunologic synapse.
Yu Y; Wang Y; Feng M
Hum Immunol; 2008 Jan; 69(1):16-23. PubMed ID: 18295671
[TBL] [Abstract][Full Text] [Related]
23. Differential down-modulation of HLA-G and HLA-A2 or -A3 cell surface expression following human cytomegalovirus infection.
Pizzato N; Garmy-Susini B; Le Bouteiller P; Lenfant F
J Reprod Immunol; 2004 Jun; 62(1-2):3-15. PubMed ID: 15288176
[TBL] [Abstract][Full Text] [Related]
24. Cellular co-localization of intron-4 containing mRNA and HLA-G soluble protein in melanoma analyzed by fluorescence in situ hybridization.
Sangrouber D; Marcou C; Le Discorde M; Chang CC; Carosella ED; Moreau P
J Immunol Methods; 2007 Sep; 326(1-2):54-62. PubMed ID: 17689555
[TBL] [Abstract][Full Text] [Related]
25. Distinct mechanisms of loss of IFN-gamma mediated HLA class I inducibility in two melanoma cell lines.
Rodríguez T; Méndez R; Del Campo A; Jiménez P; Aptsiauri N; Garrido F; Ruiz-Cabello F
BMC Cancer; 2007 Feb; 7():34. PubMed ID: 17319941
[TBL] [Abstract][Full Text] [Related]
26. Expression and regulation of non-classical HLA-G in renal cell carcinoma.
Dunker K; Schlaf G; Bukur J; Altermann WW; Handke D; Seliger B
Tissue Antigens; 2008 Aug; 72(2):137-48. PubMed ID: 18721274
[TBL] [Abstract][Full Text] [Related]
27. Soluble total human leukocyte antigen class I and human leukocyte antigen-G molecules in kidney and kidney/pancreas transplantation.
Rebmann V; Bartsch D; Wunsch A; Möllenbeck P; Golda T; Viebahn R; Grosse-Wilde H
Hum Immunol; 2009 Dec; 70(12):995-9. PubMed ID: 19651178
[TBL] [Abstract][Full Text] [Related]
28. Effect of 3-hydroxyanthranilic acid in the immunosuppressive molecules indoleamine dioxygenase and HLA-G in macrophages.
López AS; Alegre E; Díaz-Lagares A; García-Girón C; Coma MJ; González A
Immunol Lett; 2008 Apr; 117(1):91-5. PubMed ID: 18289708
[TBL] [Abstract][Full Text] [Related]
29. HLA-G1 increases the radiosensitivity of human tumoral cells.
Gallegos CE; Michelin S; Trasci SB; Lobos EA; Dubner D; Carosella ED
Cell Immunol; 2014 Feb; 287(2):106-11. PubMed ID: 24487034
[TBL] [Abstract][Full Text] [Related]
30. Expression of the non-classical HLA-G antigen in tumor cell lines is extremely restricted.
Poláková K; Russ G
Neoplasma; 2000; 47(6):342-8. PubMed ID: 11263857
[TBL] [Abstract][Full Text] [Related]
31. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
Mitsdoerffer M; Schreiner B; Kieseier BC; Neuhaus O; Dichgans J; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415
[TBL] [Abstract][Full Text] [Related]
32. [HLA-G: a tolerance molecule implicated in the escape of tumors from immunosurveillance].
Paul P; Rouas-Freiss N; Carosella ED
Pathol Biol (Paris); 1999 Oct; 47(8):766-70. PubMed ID: 10573693
[TBL] [Abstract][Full Text] [Related]
33. Analysis of HLA antigen expression in benign and malignant melanocytic lesions reveals that upregulation of HLA-G expression correlates with malignant transformation, high inflammatory infiltration and HLA-A1 genotype.
Ibrahim EC; Aractingi S; Allory Y; Borrini F; Dupuy A; Duvillard P; Carosella ED; Avril MF; Paul P
Int J Cancer; 2004 Jan; 108(2):243-50. PubMed ID: 14639610
[TBL] [Abstract][Full Text] [Related]
34. Dimerization of soluble HLA-G by IgG-Fc fragment augments ILT2-mediated inhibition of T-cell alloresponse.
Zhong M; Weng X; Liang Z; Lu S; Li J; Chen X; Li Q; Sun W; Song Y; Shen G; Wu X
Transplantation; 2009 Jan; 87(1):8-15. PubMed ID: 19136885
[TBL] [Abstract][Full Text] [Related]
35. The short cytoplasmic tail of HLA-G determines its resistance to HIV-1 Nef-mediated cell surface downregulation.
Pizzato N; Derrien M; Lenfant F
Hum Immunol; 2004 Nov; 65(11):1389-96. PubMed ID: 15556689
[TBL] [Abstract][Full Text] [Related]
36. HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells.
LeMaoult J; Krawice-Radanne I; Dausset J; Carosella ED
Proc Natl Acad Sci U S A; 2004 May; 101(18):7064-9. PubMed ID: 15103024
[TBL] [Abstract][Full Text] [Related]
37. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.
Wiendl H; Feger U; Mittelbronn M; Jack C; Schreiner B; Stadelmann C; Antel J; Brueck W; Meyermann R; Bar-Or A; Kieseier BC; Weller M
Brain; 2005 Nov; 128(Pt 11):2689-704. PubMed ID: 16123145
[TBL] [Abstract][Full Text] [Related]
38. [Establishment of eukaryotic cell line stably expressing soluble human leucocyte antigen G1 by nucleofection].
Zeng M; Fang C; Wang S
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Nov; 20(11):1130-3. PubMed ID: 17191583
[TBL] [Abstract][Full Text] [Related]
39. No expression of human leukocyte antigen G (HLA-G) in colorectal cancer cells.
Leelawat K; Engprasert S; Pongchai-rerk U; Tuchinda S; Suthipintawong C; Leardkamolkarn V
J Med Assoc Thai; 2004 Jul; 87(7):816-8. PubMed ID: 15521238
[TBL] [Abstract][Full Text] [Related]
40. Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation.
Contini P; Ghio M; Poggi A; Filaci G; Indiveri F; Ferrone S; Puppo F
Eur J Immunol; 2003 Jan; 33(1):125-34. PubMed ID: 12594841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
